Display options
Cite
Correll CU, Detraux J, De Lepeleire J, et al. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry. 2015;14(2):119-36doi: 10.1002/wps.20204.
Correll, C. U., Detraux, J., De Lepeleire, J., & De Hert, M. (2015). Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World psychiatry : official journal of the World Psychiatric Association (WPA), 14(2), 119-36. https://doi.org/10.1002/wps.20204
Correll, Christoph U, et al. "Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder." World psychiatry : official journal of the World Psychiatric Association (WPA) vol. 14,2 (2015): 119-36. doi: https://doi.org/10.1002/wps.20204
Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry. 2015 Jun;14(2):119-36. doi: 10.1002/wps.20204. PMID: 26043321; PMCID: PMC4471960.
Copy Download .nbib Format: NLM
Share it on

World Psychiatry. 2015 Jun;14(2):119-36. doi: 10.1002/wps.20204.

Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.

World psychiatry : official journal of the World Psychiatric Association (WPA)

Christoph U Correll, Johan Detraux, Jan De Lepeleire, Marc De Hert

Affiliations

  1. Department of Psychiatry, Zucker Hillside Hospital, North Shore - Long Island Jewish Health System, Glen Oaks, New York, NY, USA.
  2. Department of Psychiatry and Molecular Medicine, Hofstra North Shore LIJ School of Medicine, Hempstead, New York, NY, USA.
  3. Psychiatric Neuroscience Center of Excellence, Feinstein Institute for Medical Research, Manhasset, New York, NY, USA.
  4. Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, New York, NY, USA.
  5. Department of Neurosciences, Catholic University Leuven, B-3070 Kortenberg, Belgium.
  6. Department of Public Health and Primary Care, University of Leuven, B-3000 Leuven, Belgium.

PMID: 26043321 PMCID: PMC4471960 DOI: 10.1002/wps.20204

Abstract

People with severe mental illness have a considerably shorter lifespan than the general population. This excess mortality is mainly due to physical illness. Next to mental illness-related factors, unhealthy lifestyle, and disparities in health care access and utilization, psychotropic medications can contribute to the risk of physical morbidity and mortality. We systematically reviewed the effects of antipsychotics, antidepressants and mood stabilizers on physical health outcomes in people with schizophrenia, depression and bipolar disorder. Updating and expanding our prior systematic review published in this journal, we searched MEDLINE (November 2009 - November 2014), combining the MeSH terms of major physical disease categories (and/or relevant diseases within these categories) with schizophrenia, major depressive disorder and bipolar disorder, and the three major psychotropic classes which received regulatory approval for these disorders, i.e., antipsychotics, antidepressants and mood stabilizers. We gave precedence to results from (systematic) reviews and meta-analyses wherever possible. Antipsychotics, and to a more restricted degree antidepressants and mood stabilizers, are associated with an increased risk for several physical diseases, including obesity, dyslipidemia, diabetes mellitus, thyroid disorders, hyponatremia; cardiovascular, respiratory tract, gastrointestinal, haematological, musculoskeletal and renal diseases, as well as movement and seizure disorders. Higher dosages, polypharmacy, and treatment of vulnerable (e.g., old or young) individuals are associated with greater absolute (elderly) and relative (youth) risk for most of these physical diseases. To what degree medication-specific and patient-specific risk factors interact, and how adverse outcomes can be minimized, allowing patients to derive maximum benefits from these medications, requires adequate clinical attention and further research.

© 2015 World Psychiatric Association.

Keywords: Physical illness; antidepressants; antipsychotics; bipolar disorder; cardiovascular; depression; endocrine; gastrointestinal; metabolic; mood stabilizers; respiratory; schizophrenia

References

  1. Schizophr Bull. 2015 May;41(3):656-63 - PubMed
  2. Exp Biol Med (Maywood). 2013 Aug 1;238(8):849-58 - PubMed
  3. Biol Psychiatry. 2009 Sep 1;66(5):423-32 - PubMed
  4. Drugs Aging. 2012 May 1;29(5):359-76 - PubMed
  5. Hormones (Athens). 2013 Jul-Sep;12(3):350-62 - PubMed
  6. PLoS One. 2013 Apr 04;8(4):e59905 - PubMed
  7. Mayo Clin Proc. 2011 Apr;86(4):338-43; quiz 343 - PubMed
  8. Maturitas. 2010 Sep;67(1):1-2 - PubMed
  9. Acta Psychiatr Scand. 2007 Nov;116(5):317-33 - PubMed
  10. J Am Med Dir Assoc. 2012 Jun;13(5):413-7 - PubMed
  11. Diabetologia. 2012 Jan;55(1):10-2 - PubMed
  12. Neuropsychopharmacology. 2010 Aug;35(9):1997-2004 - PubMed
  13. Arch Intern Med. 2009 Nov 23;169(21):1952-60 - PubMed
  14. Acta Psychiatr Scand. 2013 Nov;128(5):370-5 - PubMed
  15. Arch Gen Psychiatry. 2010 Mar;67(3):220-9 - PubMed
  16. CNS Drugs. 2014 May;28(5):421-53 - PubMed
  17. Endocrine. 2015 Feb;48(1):65-8 - PubMed
  18. CNS Drugs. 2012 Sep 1;26(9):733-59 - PubMed
  19. J Psychiatr Pract. 2014 May;20(3):196-206 - PubMed
  20. Life Sci. 2013 Mar 21;92(10):525-32 - PubMed
  21. Anticancer Drugs. 2009 Sep;20(8):723-35 - PubMed
  22. J Clin Psychiatry. 2010 Oct;71(10):1259-72 - PubMed
  23. Diabetes Care. 2013 Oct;36(10):3337-45 - PubMed
  24. Compr Psychiatry. 2012 Jul;53(5):569-75 - PubMed
  25. J Psychiatry Neurosci. 2012 May;37(3):E5-6 - PubMed
  26. Am J Psychiatry. 2004 Mar;161(3):414-25 - PubMed
  27. Psychiatry (Edgmont). 2009 Jan;6(1):38-51 - PubMed
  28. Ann Pharmacother. 2009 Jan;43(1):98-103 - PubMed
  29. Curr Opin Psychiatry. 2012 Sep;25(5):415-29 - PubMed
  30. CNS Drugs. 2012 Jun 1;26(6):537-47 - PubMed
  31. CNS Drugs. 2014 Oct;28(10 ):963-73 - PubMed
  32. Curr Psychiatry Rep. 2014 Nov;16(11):499 - PubMed
  33. Osteoporos Int. 2009 Apr;20(4):585-97 - PubMed
  34. BMJ. 2009 Jul 03;339:b2452 - PubMed
  35. Arch Gen Psychiatry. 2012 May;69(5):476-83 - PubMed
  36. Ann Clin Psychiatry. 2013 Feb;25(1):17-26 - PubMed
  37. J Dent Res. 2014 Nov;93(11):1054-61 - PubMed
  38. Arch Gen Psychiatry. 2009 Dec;66(12):1354-60 - PubMed
  39. Schizophr Res. 2014 May;155(1-3):72-6 - PubMed
  40. Eur Psychiatry. 2014 Jan;29(1):1-10 - PubMed
  41. JAMA Psychiatry. 2013 Sep;70(9):931-9 - PubMed
  42. J Psychiatr Pract. 2014 Jan;20(1):50-8 - PubMed
  43. CNS Spectr. 2005 Sep;10(9):732-47 - PubMed
  44. J Affect Disord. 2012 Dec 10;141(2-3):120-9 - PubMed
  45. Osteoporos Int. 2013 Feb;24(2):671-80 - PubMed
  46. JAMA Surg. 2013 Oct;148(10):971-9 - PubMed
  47. Clin Ther. 2013 Sep;35(9):1412-7 - PubMed
  48. Curr Med Chem. 2012;19(30):5214-8 - PubMed
  49. Schizophr Res. 2014 Jul;156(2-3):168-73 - PubMed
  50. PLoS One. 2011 Apr 06;6(4):e18210 - PubMed
  51. Arch Gerontol Geriatr. 2009 Nov-Dec;49(3):390-6 - PubMed
  52. Drug Saf. 2010 Jul 1;33(7):569-78 - PubMed
  53. Schizophr Bull. 2013 Mar;39(2):295-305 - PubMed
  54. Ther Adv Drug Saf. 2013 Oct;4(5):189-98 - PubMed
  55. Bone. 2012 Oct;51(4):674-9 - PubMed
  56. J Affect Disord. 2010 Aug;124(3):319-23 - PubMed
  57. Diabetes Metab Res Rev. 2013 May;29(4):273-84 - PubMed
  58. JAMA Psychiatry. 2014 Feb;71(2):209-10 - PubMed
  59. Am J Psychiatry. 2014 Jun;171(6):616-21 - PubMed
  60. Clin Pharmacol Ther. 2014 Oct;96(4):490-7 - PubMed
  61. Schizophr Res. 2004 Dec 1;71(2-3):195-212 - PubMed
  62. Schizophr Res. 2011 May;128(1-3):161-5 - PubMed
  63. CMAJ. 2011 Apr 19;183(7):E411-9 - PubMed
  64. J Affect Disord. 2013 Aug 15;150(1):57-62 - PubMed
  65. Drugs Aging. 2012 Jan 1;29(1):15-30 - PubMed
  66. BMJ Open. 2012 Oct 08;2(5):null - PubMed
  67. Aust N Z J Psychiatry. 2009 Jan;43(1):53-60 - PubMed
  68. CNS Spectr. 2010 Sep;15(9):579-586 - PubMed
  69. Breast Cancer Res Treat. 2012 Dec;136(3):635-45 - PubMed
  70. Curr Opin Psychiatry. 2008 Mar;21(2):151-6 - PubMed
  71. Pharmacol Ther. 2010 Jan;125(1):169-79 - PubMed
  72. Schizophr Res. 2013 Jan;143(1):44-9 - PubMed
  73. PLoS One. 2014 Apr 24;9(4):e94112 - PubMed
  74. Endocrinology. 2010 Apr;151(4):1441-50 - PubMed
  75. J Clin Psychopharmacol. 2013 Jun;33(3):299-305 - PubMed
  76. Ann Pharmacother. 2012 Jul-Aug;46(7-8):917-28 - PubMed
  77. BMC Med. 2012 Nov 02;10:132 - PubMed
  78. Schizophr Bull. 2013 May;39(3):527-36 - PubMed
  79. Cell Transplant. 2009;18(9):951-75 - PubMed
  80. Am J Psychiatry. 2009 May;166(5):591-8 - PubMed
  81. Int J Neuropsychopharmacol. 2014 Jan;17 (1):41-51 - PubMed
  82. J Clin Endocrinol Metab. 2010 Sep;95(9):4124-32 - PubMed
  83. Osteoporos Int. 2009 Oct;20(10):1705-13 - PubMed
  84. J Clin Psychopharmacol. 2009 Apr;29(2):141-6 - PubMed
  85. Circulation. 2014 Jul 15;130(3):235-43 - PubMed
  86. Ann Intern Med. 2012 Oct 2;157(7):498-511 - PubMed
  87. Am J Psychiatry. 2014 Apr;171(4):404-15 - PubMed
  88. Breast Cancer Res Treat. 2011 Sep;129(2):541-8 - PubMed
  89. Schizophr Res. 2011 Jul;129(2-3):97-103 - PubMed
  90. Br J Clin Pharmacol. 2011 Dec;72(6):871-8 - PubMed
  91. Clin Pharmacol Ther. 2011 Jun;89(6):880-7 - PubMed
  92. Acta Psychiatr Scand. 2016 Jan;133(1):5-22 - PubMed
  93. World Psychiatry. 2011 Feb;10(1):52-77 - PubMed
  94. Osteoporos Int. 2013 Jan;24(1):121-37 - PubMed
  95. Bone. 2009 Feb;44(2):331-4 - PubMed
  96. Nat Rev Endocrinol. 2011 Oct 18;8(2):114-26 - PubMed
  97. Psychother Psychosom. 2014;83(2):89-105 - PubMed
  98. Curr Drug Saf. 2011 Nov 1;6(5):291-303 - PubMed
  99. Psychol Med. 2014 Jul;44(10):2017-28 - PubMed
  100. Gen Hosp Psychiatry. 2013 Jan-Feb;35(1):16-22 - PubMed
  101. Osteoporos Int. 2014 May;25(5):1473-81 - PubMed
  102. J Affect Disord. 2010 Nov;126(3):436-40 - PubMed
  103. J Clin Psychopharmacol. 2014 Feb;34(1):40-6 - PubMed
  104. Psychopharmacol Bull. 2009;42(1):11-31 - PubMed
  105. Neuropsychopharmacology. 2003 Jan;28(1):182-92 - PubMed
  106. Diabetes Care. 2010 Dec;33(12):2611-6 - PubMed
  107. Eur Psychiatry. 2012 Apr;27(3):156-69 - PubMed
  108. J Clin Psychiatry. 2014 Jan;75(1):46-61 - PubMed
  109. Nat Rev Endocrinol. 2015 Feb;11(2):79-89 - PubMed
  110. Prim Care Companion CNS Disord. 2011;13(6):null - PubMed
  111. Schizophr Bull. 2013 Mar;39(2):306-18 - PubMed
  112. Eur Psychiatry. 2011 Apr;26(3):144-58 - PubMed
  113. Ann Clin Psychiatry. 2011 Feb;23(1):40-7 - PubMed
  114. Pharmacotherapy. 2006 Jun;26(6):748-58 - PubMed
  115. Acta Psychiatr Scand. 2014 Dec;130(6):470-86 - PubMed
  116. Biol Psychiatry. 2013 Jul 1;74(1):32-9 - PubMed
  117. Am J Psychiatry. 2013 Mar;170(3):265-74 - PubMed
  118. N Engl J Med. 2009 Jan 15;360(3):225-35 - PubMed
  119. Diabetes Res Clin Pract. 2008 Jan;79(1):61-7 - PubMed
  120. Curr Psychiatry Rep. 2011 Aug;13(4):295-304 - PubMed
  121. Psychiatr Danub. 2013 Dec;25(4):410-5 - PubMed
  122. Schizophr Res. 2010 Nov;123(2-3):225-33 - PubMed
  123. J Am Geriatr Soc. 2012 Mar;60(3):420-9 - PubMed
  124. Schizophr Res. 2013 Oct;150(1):274-80 - PubMed
  125. Curr Opin Psychiatry. 2013 Jan;26(1):60-5 - PubMed
  126. Ann N Y Acad Sci. 2010 Mar;1192:170-5 - PubMed
  127. East Asian Arch Psychiatry. 2013 Mar;23(1):21-8 - PubMed
  128. Horm Metab Res. 2010 Jun;42(7):467-82 - PubMed
  129. Pharmacotherapy. 2013 Oct;33(10):1053-61 - PubMed
  130. Eur Heart J. 2015 Apr 21;36(16):984-92 - PubMed
  131. Schizophr Res. 2013 Nov;150(2-3):398-403 - PubMed
  132. Int Clin Psychopharmacol. 2011 May;26(3):159-68 - PubMed
  133. Kidney Int. 2010 Feb;77(3):219-24 - PubMed
  134. Diabetes Care. 2008 Mar;31(3):420-6 - PubMed
  135. Biol Psychiatry. 2011 Nov 15;70(10):978-84 - PubMed
  136. Front Oncol. 2012 Dec 05;2:177 - PubMed
  137. Am J Public Health. 2013 Aug;103(8):e34-43 - PubMed
  138. Expert Rev Neurother. 2006 Apr;6(4):575-89 - PubMed
  139. Expert Rev Hematol. 2011 Apr;4(2):143-51 - PubMed
  140. Arch Intern Med. 2012 Apr 23;172(8):648-53; discussion 654-5 - PubMed
  141. J Child Adolesc Psychopharmacol. 2011 Dec;21(6):517-35 - PubMed
  142. J Clin Psychiatry. 2013 Dec;74(12):1199-206 - PubMed
  143. J Psychiatr Res. 2013 Nov;47(11):1549-56 - PubMed
  144. CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62 - PubMed
  145. Bone. 2012 Sep;51(3):606-13 - PubMed
  146. Drug Saf. 2013 Jun;36(6):467-79 - PubMed
  147. World Psychiatry. 2014 Jun;13(2):153-60 - PubMed
  148. Adv Ther. 2009 Apr;26(4):404-24 - PubMed
  149. Schizophr Res. 2014 Nov;159(2-3):322-8 - PubMed
  150. Drug Saf. 2010 Feb 1;33(2):101-14 - PubMed
  151. J Clin Psychiatry. 2005 Jan;66(1):80-4 - PubMed
  152. Curr Psychiatry Rep. 2012 Dec;14(6):650-8 - PubMed
  153. Schizophr Res. 2011 Sep;131(1-3):101-4 - PubMed
  154. Lancet. 2012 Feb 25;379(9817):721-8 - PubMed
  155. Int J Cardiol. 2009 Feb 6;132(1):30-7 - PubMed
  156. CMAJ. 2013 Jan 8;185(1):E50-6 - PubMed
  157. PLoS One. 2011;6(7):e22274 - PubMed
  158. Calcif Tissue Int. 2011 Jun;88(6):476-84 - PubMed
  159. J Clin Psychopharmacol. 2010 Jun;30(3):282-5 - PubMed
  160. Schizophr Bull. 2013 May;39(3):648-57 - PubMed
  161. Ann Med. 2013 Mar;45(2):171-81 - PubMed
  162. Curr Opin Psychiatry. 2012 Mar;25(2):83-8 - PubMed
  163. Schizophr Res. 2010 Mar;117(1):75-82 - PubMed
  164. CNS Drugs. 2013 Dec;27(12):1069-80 - PubMed
  165. Front Psychiatry. 2014 Sep 26;5:137 - PubMed
  166. Psychiatr Serv. 2009 Feb;60(2):147-56 - PubMed
  167. Expert Opin Drug Saf. 2011 Jul;10(4):575-602 - PubMed
  168. Age Ageing. 2013 Jul;42(4):514-20 - PubMed
  169. Am J Surg Pathol. 2012 Nov;36(11):1724-8 - PubMed
  170. Circ Arrhythm Electrophysiol. 2014 Jun;7(3):384-91 - PubMed
  171. Korean J Fam Med. 2013 Jul;34(4):228-40 - PubMed
  172. Asian J Psychiatr. 2011 Jun;4(2):139-43 - PubMed
  173. J Clin Psychiatry. 2013 Jan;74(1):e79-86 - PubMed
  174. J Clin Psychiatry. 2010 Jul;71(7):949-54 - PubMed
  175. J Clin Psychiatry. 2013 Jun;74(6):603-13; quiz 613 - PubMed
  176. J Clin Psychiatry. 2009 May;70(5):765-6 - PubMed
  177. Can J Psychiatry. 2010 Dec;55(12):752-60 - PubMed
  178. Schizophr Res. 2014 Aug;157(1-3):137-41 - PubMed
  179. Br J Gen Pract. 2010 Oct;60(579):e385-94 - PubMed
  180. CNS Drugs. 2010 Jul;24(7):563-74 - PubMed
  181. Acta Psychiatr Scand. 2015 Mar;131(3):213-22 - PubMed
  182. BMC Public Health. 2010 Jul 06;10:396 - PubMed
  183. Am J Gastroenterol. 2013 Jun;108(6):866-72 - PubMed
  184. Psychopharmacology (Berl). 2013 Feb;225(3):505-18 - PubMed
  185. Trends Endocrinol Metab. 2014 Nov;25(11):593-600 - PubMed
  186. Int J Methods Psychiatr Res. 2014 Mar;23(1):19-24 - PubMed
  187. Lancet. 2009 Aug 22;374(9690):620-7 - PubMed
  188. CNS Drugs. 2010 Jan;24(1):35-53 - PubMed
  189. Drug Saf. 2010 Apr 1;33(4):273-88 - PubMed
  190. Evid Based Ment Health. 2013 Nov;16(4):109 - PubMed
  191. Schizophr Res. 2009 May;110(1-3):103-10 - PubMed
  192. Schizophr Res. 2013 May;146(1-3):190-5 - PubMed
  193. Arch Gen Psychiatry. 2002 Dec;59(12):1147-54 - PubMed
  194. Expert Rev Neurother. 2009 Jan;9(1):137-41 - PubMed
  195. J Clin Psychiatry. 2010 Mar;71(3):338-47 - PubMed
  196. Trends Endocrinol Metab. 2009 Oct;20(8):367-73 - PubMed
  197. Osteoporos Int. 2009 Sep;20(9):1499-506 - PubMed
  198. Schizophr Bull. 2013 Mar;39(2):407-16 - PubMed
  199. Nat Rev Nephrol. 2009 May;5(5):270-6 - PubMed
  200. CNS Drugs. 2013 Apr;27(4):249-57 - PubMed
  201. Expert Opin Drug Metab Toxicol. 2014 May;10(5):721-46 - PubMed
  202. JAMA Psychiatry. 2014 Aug;71(8):889-96 - PubMed
  203. J Psychopharmacol. 2010 Oct;24(10):1425-31 - PubMed
  204. Arthritis Care Res (Hoboken). 2012 Dec;64(12):1855-63 - PubMed
  205. World J Biol Psychiatry. 2013 Feb;14(1):2-44 - PubMed
  206. Expert Opin Drug Saf. 2006 Jul;5(4):523-37 - PubMed
  207. Psychosomatics. 2014 Nov-Dec;55(6):536-47 - PubMed
  208. J Am Med Dir Assoc. 2010 Feb;11(2):120-7 - PubMed
  209. Cardiovasc Psychiatry Neurol. 2013;2013:247486 - PubMed
  210. CNS Drugs. 2014 Oct;28(10):887-920 - PubMed
  211. Age Ageing. 2013 May;42(3):318-24 - PubMed
  212. JAMA Psychiatry. 2013 Jan;70(1):22-30 - PubMed
  213. Expert Rev Neurother. 2014 May;14(5):539-51 - PubMed
  214. Health Technol Assess. 2011 Aug;15(28):1-202, iii-iv - PubMed
  215. Psychopharmacology (Berl). 2013 Mar;226(1):1-12 - PubMed
  216. Clin Neuropharmacol. 2012 Sep-Oct;35(5):244-53 - PubMed
  217. Curr Drug Saf. 2013 Jul;8(3):207-23 - PubMed
  218. Evid Based Ment Health. 2009 Feb;12(1):25 - PubMed
  219. J Am Geriatr Soc. 2013 May;61(5):715-22 - PubMed
  220. PLoS One. 2013 Nov 20;8(11):e81208 - PubMed
  221. Eur Neuropsychopharmacol. 2013 Aug;23(8):872-8 - PubMed
  222. Br J Psychiatry. 2010 Feb;196(2):116-21 - PubMed
  223. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:92-9 - PubMed
  224. Curr Psychiatry Rev. 2012 Feb 1;8(1):25-36 - PubMed
  225. Drug Saf. 2011 Jul 1;34(7):567-75 - PubMed
  226. Innov Clin Neurosci. 2012 Jul;9(7-8):42-7 - PubMed
  227. Bipolar Disord. 2011 Jun;13(4):387-95 - PubMed
  228. Lancet. 2013 Sep 14;382(9896):951-62 - PubMed
  229. J Geriatr Psychiatry Neurol. 2012 Mar;25(1):51-61 - PubMed
  230. J Clin Exp Cardiolog. 2013;Suppl 10(6):1-9 - PubMed
  231. Psychiatr Serv. 2011 Oct;62(10 ):1152-8 - PubMed
  232. Eur Psychiatry. 2011 Jan;26(1):34-44 - PubMed
  233. Hum Psychopharmacol. 2012 Jan;27(1):15-23 - PubMed
  234. Int J Neuropsychopharmacol. 2013 Jun;16(5):987-95 - PubMed
  235. Am J Geriatr Pharmacother. 2012 Apr;10 (2):83-94 - PubMed
  236. Pharmacoepidemiol Drug Saf. 2009 Sep;18(9):791-9 - PubMed
  237. Expert Opin Drug Saf. 2014 Feb;13(2):197-205 - PubMed
  238. J Cell Biochem. 2009 Jul 1;107(4):677-85 - PubMed
  239. J Affect Disord. 2010 Apr;122(1-2):118-23 - PubMed
  240. Ann Clin Psychiatry. 2012 Aug;24(3):225-39 - PubMed
  241. Lancet. 2009 Jan 3;373(9657):31-41 - PubMed
  242. World Psychiatry. 2013 Oct;12(3):240-50 - PubMed
  243. Epilepsy Res. 2013 Nov;107(1-2):1-8 - PubMed
  244. Br J Psychiatry. 2008 Jun;192(6):406-11 - PubMed
  245. Int J Endocrinol. 2013;2013:167138 - PubMed
  246. Endocrinol Metab Clin North Am. 2013 Sep;42(3):545-63 - PubMed
  247. Postgrad Med. 2012 Jul;124(4):154-67 - PubMed
  248. Schizophr Res. 2005 Dec 1;80(1):19-32 - PubMed
  249. BMJ. 2013 Jun 27;346:f3646 - PubMed
  250. Drugs Aging. 2010 Oct 1;27(10):815-29 - PubMed
  251. BMC Geriatr. 2010 Jul 06;10:45 - PubMed
  252. Hum Psychopharmacol. 2010 Jun-Jul;25(4):281-97 - PubMed
  253. Clin Psychopharmacol Neurosci. 2012 Aug;10(2):71-7 - PubMed
  254. Hum Psychopharmacol. 2008 Jan;23 Suppl 1:15-26 - PubMed
  255. J Psychopharmacol. 2013 Aug;27(8):732-9 - PubMed
  256. World Psychiatry. 2015 Feb;14(1):56-63 - PubMed
  257. Med Hypotheses. 2012 Jul;79(1):38-42 - PubMed
  258. Schizophr Res. 2012 Feb;134(2-3):180-6 - PubMed
  259. Neuropsychopharmacology. 2011 Jul;36(8):1738-46 - PubMed
  260. J Clin Psychiatry. 2014 May;75(5):e441-9 - PubMed
  261. Cancer Sci. 2013 Mar;104(3):383-90 - PubMed
  262. JAMA Psychiatry. 2013 Oct;70(10):1067-75 - PubMed
  263. J Psychiatr Res. 2013 Jul;47(7):851-7 - PubMed
  264. Eur Psychiatry. 2010 Jun;25 Suppl 2:S12-21 - PubMed
  265. Schizophr Res. 2009 Jun;111(1-3):9-16 - PubMed
  266. Psychosomatics. 2013 Jan-Feb;54(1):1-13 - PubMed
  267. Curr Infect Dis Rep. 2011 Jun;13(3):262-8 - PubMed
  268. Gen Hosp Psychiatry. 2012 Jan-Feb;34(1):53-61 - PubMed
  269. Psychiatr Serv. 2012 Jul;63(7):714-7 - PubMed
  270. Psychol Med. 2009 Jul;39(7):1065-76 - PubMed
  271. Psychiatry Investig. 2011 Sep;8(3):256-61 - PubMed
  272. PLoS One. 2014 Aug 20;9(8):e105376 - PubMed
  273. Early Interv Psychiatry. 2014 Aug;8(3):276-80 - PubMed
  274. Bone. 2010 Sep;47(3):604-9 - PubMed
  275. Ann Intern Med. 2010 Apr 6;152(7):418-25, W139-40 - PubMed
  276. Psychosom Med. 2011 Sep;73(7):620-6 - PubMed
  277. Psychosomatics. 2009 Jul-Aug;50(4):317-24 - PubMed
  278. Osteoporos Int. 2012 Jan;23(1):365-75 - PubMed
  279. Psychosomatics. 2013 Jan-Feb;54(1):67-73 - PubMed
  280. Am J Psychiatry. 2002 Apr;159(4):561-6 - PubMed
  281. Curr Drug Saf. 2010 Jan;5(1):97-104 - PubMed
  282. Asia Pac J Public Health. 2013 Sep;25(5):368-87 - PubMed

Publication Types